Mast cells promote pathology and susceptibility in tuberculosis
Ananya Gupta,Vibha Taneja,Javier Rangel Moreno,Abhimanyu,Mushtaq Ahmed,Nilofer Naqvi,Kuldeep S. Chauhan,Daniela Trejo-Ponce de León,Gustavo Ramírez-Martínez,Luis Jiménez-Alvarez,Cesar Luna-Rivero,Joaquin Zuniga,Deepak Kaushal,Shabaana A. Khader
DOI: https://doi.org/10.1101/2024.09.04.611333
2024-09-10
Abstract:Tuberculosis (TB), caused by the bacterium ( ), infects approximately one-fourth of the world’s population. While most infected individuals are asymptomatic, latent TB infection (LTBI) can progress to cause pulmonary TB (PTB). We recently reported an increased accumulation of mast cells (MCs) in lungs of macaques with PTB, compared with LTBI in macaques. MCs respond in vitro to exposure via degranulation and by inducing proinflammatory cytokines. In the current study, we show the dominant production of chymase by MCs in granulomas of humans and macaques with PTB. Using scRNA seq analysis, we show that MCs found in LTBI and healthy lungs in macaques are enriched in genes involved in tumor necrosis factor alpha, cholesterol and transforming growth factor beta signaling. In contrast, MCs clusters found in PTB express transcriptional signatures associated with interferon gamma, oxidative phosphorylation, and MYC signaling. Additionally, MC deficiency in the mouse model showed improved control of infection that coincided with reduced accumulation of lung myeloid cells and diminished inflammation at chronic stages. Thus, these collective results provide novel evidence for the pathological contribution of MCs during infection and may represent a novel target for host directive therapy for TB.
Immunology
What problem does this paper attempt to address?